Founded
Address
Thomas McNerney & Partners LLC
One Stamford Plaza 263 Tresser Blvd 16th Floor
Suite 1600
Stamford, CT 06901
United States
Phone
Website
Recent investment activity
KANDO id: 3811
Corporate information
Registration country
Company type
Healthcare venture firm.Overview
Thomas, McNerney & Partners is a health care venture firm that invested in life science and medical technology companies at all stages of development. The Thomas, McNerney & Partners team has significant experience in helping entrepreneurs start companies, in providing growth capital to emerging companies and in undertaking restructuring transactions such as spin-outs, roll-ups and recapitalizations.Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 26 - 34 of 34| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Altair Therapeutics Inc | Developing novel therapeutics to treat human respiratory diseases. | Series B Repeat investment. | |||
|
|
Altair Therapeutics Inc | Developing novel therapeutics to treat human respiratory diseases. | Series A | |||
|
|
Auspex Pharmaceuticals Inc | Series C | ||||
|
|
Auspex Pharmaceuticals Inc | Series B | ||||
|
|
Axiomed Spine Corp | Provider of lumbar disc replacement for restoring spinal function to patients with degenerative spine disease. | Series D | |||
|
|
Coulter Pharmaceutical Inc | N/A | ||||
|
|
Solstice Neurosciences | Series B Initial investment | ||||
|
|
Solstice Neurosciences | Venture Initial investment | ||||
|
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | Series B Initial investment |